
    
      A randomized clinical trial in a tertiary academic center in patients with cardiac surgery,
      to receive either nitroglycerin infusion dose of 0-0.1 mcg/kg/min, or 1-5 mcg/kg/min during
      rewarming in cardiopulmonary bypass.
    
  